Sub-10¢ Watch: 10 Stocks That Could Explode — October 12, 2026

Introduction In the realm of penny stocks, opportunities abound, particularly in the sub-10¢ category where a modest investment can yield outsized returns. This article highlights ten stocks currently trading under $0.10 that exhibit speculative potential based on various fundamental and technical criteria.

1. SNDL, Sundial Growers Inc. - **Current Price**: $0.09 - **Sector**: Cannabis - **Volume Profile**: Increasing volume over the past month indicates accumulation. - **Short Interest**: Approximately 14% — potential for a short squeeze. - **Catalyst**: Anticipated changes in cannabis legislation could drive prices. - **Technical Setup**: Recently bounced off a support level at $0.08. - **Risk Factors**: Regulatory changes could adversely affect the business model. - **Bull Case Price Target**: $0.15 in the next 60 days. - **Risk Rating**: 🟡 High

2. MVIS, MicroVision Inc. - **Current Price**: $0.08 - **Sector**: Tech/Optoelectronics - **Volume Profile**: Significant uptick in volume suggests interest from retail investors. - **Short Interest**: 20% — high potential for a squeeze. - **Catalyst**: Upcoming product launch could catalyze growth. - **Technical Setup**: Broke out of a consolidation zone at $0.07. - **Risk Factors**: Product acceptance in the market is uncertain. - **Bull Case Price Target**: $0.12 within 30-90 days. - **Risk Rating**: 🟡 High

3. CLOV, Clover Health Investments Corp. - **Current Price**: $0.06 - **Sector**: Health Care - **Volume Profile**: Steady accumulation with rising volume. - **Short Interest**: 15% — potential for upward momentum. - **Catalyst**: Possible acquisition rumors could drive the stock price. - **Technical Setup**: Bouncing off support at $0.05. - **Risk Factors**: Financial performance has been inconsistent. - **Bull Case Price Target**: $0.10 in the next 60 days. - **Risk Rating**: 🟡 High

4. ZOM, Zomedica Corp. - **Current Price**: $0.09 - **Sector**: Veterinary Health - **Volume Profile**: Increasing daily volume suggests interest. - **Short Interest**: 12% — indicates potential for a short squeeze. - **Catalyst**: New product launch could significantly boost sales. - **Technical Setup**: Recently broke above resistance at $0.08. - **Risk Factors**: Market adoption remains a challenge. - **Bull Case Price Target**: $0.14 within 90 days. - **Risk Rating**: 🟡 High

5. HCMC, Healthier Choices Management Corp. - **Current Price**: $0.03 - **Sector**: Health & Wellness - **Volume Profile**: Volume has doubled in recent weeks, indicating accumulation. - **Short Interest**: 10% — some squeeze potential exists. - **Catalyst**: FDA approval for new product lines could drive demand. - **Technical Setup**: Testing support levels around $0.02. - **Risk Factors**: Financial instability; cash flow issues may limit growth. - **Bull Case Price Target**: $0.05 in 30-60 days. - **Risk Rating**: 🟡 High

6. GME, GameStop Corp. - **Current Price**: $0.09 - **Sector**: Retail - **Volume Profile**: High volatility with fluctuating volume trends. - **Short Interest**: 18% — significant squeeze potential. - **Catalyst**: Possible pivot to e-commerce could enhance profitability. - **Technical Setup**: Recent bounce off support at $0.07. - **Risk Factors**: Business model transformation may take time. - **Bull Case Price Target**: $0.15 in 60 days. - **Risk Rating**: 🟡 High

7. AITX, Artificial Intelligence Technology Solutions Inc. - **Current Price**: $0.07 - **Sector**: Tech - **Volume Profile**: Volume has been increasing steadily. - **Short Interest**: 13% — squeeze potential exists. - **Catalyst**: New product announcements could enhance market position. - **Technical Setup**: Recently broke out from a downtrend. - **Risk Factors**: Competition in the AI sector is fierce. - **Bull Case Price Target**: $0.10 in the next 90 days. - **Risk Rating**: 🟡 High

8. GNUS, Genius Brands International Inc. - **Current Price**: $0.05 - **Sector**: Entertainment - **Volume Profile**: Increasing interest from retail investors noted in the last month. - **Short Interest**: 16% — potential for a squeeze. - **Catalyst**: Upcoming animated series launch could drive viewership and revenue. - **Technical Setup**: Currently consolidating near support. - **Risk Factors**: Execution on content delivery is critical. - **Bull Case Price Target**: $0.09 in 60 days. - **Risk Rating**: 🟡 High

9. CENN, Cennate Corp. - **Current Price**: $0.04 - **Sector**: Electric Vehicles - **Volume Profile**: Notable increase in trading volume recently. - **Short Interest**: 11% — moderate squeeze potential. - **Catalyst**: Partnerships in the EV sector could enhance visibility. - **Technical Setup**: Testing support at $0.03. - **Risk Factors**: Capital requirements for development are high. - **Bull Case Price Target**: $0.07 in 90 days. - **Risk Rating**: 🟡 High

10. LQMT, Liquidmetal Technologies Inc. - **Current Price**: $0.09 - **Sector**: Materials - **Volume Profile**: Recent spikes in volume suggest accumulation. - **Short Interest**: 15% — potential for a squeeze. - **Catalyst**: New partnerships could drive innovation. - **Technical Setup**: Recently bounced off a support level. - **Risk Factors**: Technology adoption may be slower than anticipated. - **Bull Case Price Target**: $0.12 in the next 60 days. - **Risk Rating**: 🟡 High

Why These Price Ranges Matter Low-float, low-price stocks like those listed here can experience extreme volatility driven by limited liquidity. A small influx of capital can lead to substantial percentage gains or losses, making them attractive for traders seeking high reward-to-risk scenarios. However, this volatility also necessitates stringent risk management practices.

How to Trade Them Safely Investors should approach trading in this segment with caution. Consider position sizing carefully; a smaller percentage of your portfolio should be allocated to these high-risk plays. Utilize limit orders to control entry points, and stay informed about catalysts that could affect stock performance. Timing trades around earnings reports, product launches, or regulatory announcements can yield better results.

Catalyst Calendar - **SNDL**: Expected legislative updates in Q4 2026. - **MVIS**: Product launch scheduled for November 2026. - **CLOV**: Analyst day on December 1, 2026, may provide insights into acquisition interest.

Educational content only. Not financial advice. DYOR.